Yes I have been wondering if they have been looking at the data of each individual as they hit the 30 day mortality period. This still leaves the blinding in tact for those who have not completed their 30 days while giving indication of how the drug is tracking. This way they would also know what the results are going to be, and on which day they will be valid due to the recruitment numbers.... But I don't know how they are doing it. This was just my musing.
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-98
-
- There are more pages in this discussion • 328 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |